dixit
★    

India,
2009-03-17 18:45
(5900 d 14:39 ago)

Posting: # 3375
Views: 5,693
 

 detection of Anomalies/ outliers [Outliers]

Dear all,
Can any one please tell me what are the different criteria for detection of outliers or PK anomalies in a given pharmacokinetic data. And please tell me the different conditions under which a subject's PK values are rejected from the data.


REGARDS
DIXIT ;-)
JPL
☆    

Vienna,
2009-03-24 10:50
(5893 d 22:34 ago)

@ dixit
Posting: # 3397
Views: 4,476
 

 detection of Anomalies/ outliers

HI Dixit,

excluding single measurements (1) from PK analysis is a rather different topic than excluding a whole patient (2).

@(1) If a PK-measurement increases within one patient at a certain time point, this measurement might be exclude from calculation of half-life.

@(2) If a patient does violate prespecified criteria, he may be excluded from the analysis (however, often a ITT and PP analysis is performed).

For both cases: if there is a documented violation obviously influencing the measurement(s), data can be excluded.

In all cases a rationale must be given. Exclusion of data because of departure of (say) more than 3 SD from the global mean is never accepted.
Those analyses can be used in best case as secondary analyses to investigate in amount of influence of the outliers.

Regards,
JPL
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
93 visitors (0 registered, 93 guests [including 55 identified bots]).
Forum time: 10:24 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5